Patent Assignment
Reel/Frame 065658/0280
Change of Name
Recorded: 2023-11-21
Pages: 2
Assignor
HUIGENE THERAPEUTICS CO., LTD.
Executed: 2023-01-28
Assignee
HUIDAGENE THERAPEUTICS CO., LTD.
ROOM 1002, BUILDING #7-1, NO. 160 BASHENG ROAD, PUDONG DISTRICT, SHANGHAI, 201203, CHINA
Covered Property
(1)
Type Vi-E and Type Vi-F Crispr-Cas System and Uses Thereof
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 5, 2022
From: YANG, HUI; XU, CHUNLONG; ZHOU, YINGSI; XIAO, QINGQUAN
To: CENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
Reel/Frame 058560/0693 →
Assignment of Assignor's Interest
Jan 7, 2022
From: CENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
To: HUIGENE THERAPEUTICS CO., LTD.
Reel/Frame 058583/0829 →
Assignment of Assignor's Interest
Nov 22, 2023
From: HUIDAGENE THERAPEUTICS CO., LTD.
To: HUIDAGENE THERAPEUTICS (SINGAPORE) PTE. LTD.
Reel/Frame 065646/0545 →